Oral tinidazole treatment during pregnancy and teratogenesis.
Czeizel
A E
AE
Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary. czeizel@interware.hu
Kazy
Z
Z
Vargha
P
P
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology* / Q000209:etiology*; D000284:Administration, Oral; D000328:Adult; D000994:Antitrichomonal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D015994:Incidence; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012042:Registries; D018570:Risk Assessment; D011795:Surveys and Questionnaires; D013723:Teratogens; D014011:Tinidazole / Q000009:adverse effects* / Q000627:therapeutic use
D000994:Antitrichomonal Agents; D013723:Teratogens; D014011:Tinidazole